RCKT Crosses Above Average Analyst Target
December 10, 2020 at 08:02 AM EST
In recent trading, shares of Rocket Pharmaceuticals Inc (RCKT) have crossed above the average analyst 12-month target price of $40.43, changing hands for $58.74/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..